Kurt R. Gehlsen
Chief Tech/Sci/R&D Officer at Biorasi LLC
Profile
Kurt R.
Gehlsen is currently the Chief Scientific Officer & Vice President at Biorasi LLC.
Previously, he worked as the Chief Science Officer at Maxim Pharmaceuticals, Inc. from 1996 to 2006.
He also held a position as a Principal at the California Institute of Technology.
Dr. Gehlsen obtained his undergraduate and doctorate degrees from the University of Arizona.
Kurt R. Gehlsen active positions
Companies | Position | Start |
---|---|---|
Biorasi LLC
Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Chief Tech/Sci/R&D Officer | 2019-01-28 |
Former positions of Kurt R. Gehlsen
Companies | Position | End |
---|---|---|
Maxim Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 2006-01-05 |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | Corporate Officer/Principal | - |
Training of Kurt R. Gehlsen
University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Maxim Pharmaceuticals, Inc. | Health Technology |
Biorasi LLC
Biorasi LLC BiotechnologyHealth Technology Biorasi LLC operates as a contract research organization specializes in the development of therapeutics. It provides services, including program management, regulatory services, including trial approval services, interim and post trial regulatory management, and marketing approval/registration services and clinical services, including training, monitoring, and issue resolution. The company was founded by Boris N. Reznik in 2002 and is headquartered in Miami, FL. | Health Technology |
- Stock Market
- Insiders
- Kurt R. Gehlsen